(Q39712243)

14 September 2017

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia (English)

1 reference

14 September 2017

1 reference

14

H Hasle

1 reference

14 September 2017

A Yoshimi

1

1 reference

14 September 2017

P Bader

2

1 reference

14 September 2017

S Matthes-Martin

3

1 reference

14 September 2017

J Starý

4

1 reference

14 September 2017

P Sedlacek

5

1 reference

14 September 2017

U Duffner

6

1 reference

14 September 2017

T Klingebiel

7

1 reference

14 September 2017

D Dilloo

8

1 reference

14 September 2017

W Holter

9

1 reference

14 September 2017

F Zintl

10

1 reference

14 September 2017

B Kremens

11

1 reference

14 September 2017

K-W Sykora

12

1 reference

14 September 2017

C Urban

13

1 reference

14 September 2017

E Korthof

15

1 reference

14 September 2017

T Révész

16

1 reference

14 September 2017

A Fischer

17

1 reference

14 September 2017

P Nöllke

18

1 reference

14 September 2017

F Locatelli

19

1 reference

14 September 2017

C M Niemeyer

20

1 reference

14 September 2017

European Working Group of MDS in Childhood (EWOG-MDS)

21

1 reference

14 September 2017

1 June 2005

1 reference

14 September 2017

1 reference

14 September 2017

19

1 reference

14 September 2017

6

1 reference

14 September 2017

971-977

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403721

14 September 2017

0 references

cites work

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Extramedullary relapse despite graft-versus-leukemia effect after bone marrow transplantation in a girl with juvenile myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical-biological situations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Haemopoietic cell transplantation in children with juvenile myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403721

1 reference

14 September 2017

1 reference